PKM and cancer: Similarly, the inhibition of pyruvate kinase isozyme M2 (PKM2) has been studied in RA [109,110] for its anti-inflammatory property, as well as in cancer [94,143,144] where it is involved in the bypass of cancer cells drug resistance.